1. Home
  2. CVAC vs ACDC Comparison

CVAC vs ACDC Comparison

Compare CVAC & ACDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • ACDC
  • Stock Information
  • Founded
  • CVAC 2000
  • ACDC 2014
  • Country
  • CVAC Germany
  • ACDC United States
  • Employees
  • CVAC N/A
  • ACDC N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • ACDC Oilfield Services/Equipment
  • Sector
  • CVAC Health Care
  • ACDC Energy
  • Exchange
  • CVAC Nasdaq
  • ACDC Nasdaq
  • Market Cap
  • CVAC 1.2B
  • ACDC 1.1B
  • IPO Year
  • CVAC 2020
  • ACDC 2022
  • Fundamental
  • Price
  • CVAC $5.41
  • ACDC $7.79
  • Analyst Decision
  • CVAC Hold
  • ACDC Sell
  • Analyst Count
  • CVAC 3
  • ACDC 4
  • Target Price
  • CVAC $6.83
  • ACDC $6.50
  • AVG Volume (30 Days)
  • CVAC 974.0K
  • ACDC 776.8K
  • Earning Date
  • CVAC 08-14-2025
  • ACDC 08-07-2025
  • Dividend Yield
  • CVAC N/A
  • ACDC N/A
  • EPS Growth
  • CVAC N/A
  • ACDC N/A
  • EPS
  • CVAC 0.87
  • ACDC N/A
  • Revenue
  • CVAC $566,039,775.00
  • ACDC $2,209,700,000.00
  • Revenue This Year
  • CVAC N/A
  • ACDC N/A
  • Revenue Next Year
  • CVAC $24.04
  • ACDC $0.38
  • P/E Ratio
  • CVAC $6.26
  • ACDC N/A
  • Revenue Growth
  • CVAC 787.60
  • ACDC N/A
  • 52 Week Low
  • CVAC $2.37
  • ACDC $3.83
  • 52 Week High
  • CVAC $5.72
  • ACDC $10.70
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 61.38
  • ACDC 48.15
  • Support Level
  • CVAC $5.42
  • ACDC $7.58
  • Resistance Level
  • CVAC $5.49
  • ACDC $8.31
  • Average True Range (ATR)
  • CVAC 0.07
  • ACDC 0.62
  • MACD
  • CVAC -0.06
  • ACDC -0.09
  • Stochastic Oscillator
  • CVAC 52.38
  • ACDC 47.76

About CVAC CureVac N.V.

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About ACDC ProFrac Holding Corp.

ProFrac Holding Corp is engaged in providing hydraulic fracturing, completion services, and other complementary products and services to upstream oil and gas companies engaged in the exploration and production of North American unconventional oil and natural gas resources. Its operations are focused in West Texas, East Texas/Louisiana, South Texas, Oklahoma, Uinta, and Appalachian. The company operates in three segments: Stimulation Services, Proppant Production, and Manufacturing. Stimulation services, which generate the majority of the revenue for the company operate a fleet of mobile hydraulic fracturing units and other auxiliary equipment that generates revenue by providing stimulation services.

Share on Social Networks: